Seattle Genetics plans more clinical tests
Published 9:39 am Friday, April 25, 2008
Clay Siegall, Seattle Genetics’ president and chief executive officer, said the company’s three leading drug candidates are moving well through clinical trials.
cmg-northwest2.go-vip.net/heraldnet/article/20080425/BIZ/779506074/1005
